ATE456302T1 - Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe - Google Patents
Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebeInfo
- Publication number
- ATE456302T1 ATE456302T1 AT98946099T AT98946099T ATE456302T1 AT E456302 T1 ATE456302 T1 AT E456302T1 AT 98946099 T AT98946099 T AT 98946099T AT 98946099 T AT98946099 T AT 98946099T AT E456302 T1 ATE456302 T1 AT E456302T1
- Authority
- AT
- Austria
- Prior art keywords
- arginine
- administration
- tissue
- relief
- warm cold
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 4
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 208000005230 Leg Ulcer Diseases 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 210000004761 scalp Anatomy 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/932,227 US7914814B2 (en) | 1997-09-17 | 1997-09-17 | Topical delivery of arginine of cause beneficial effects |
US08/936,189 US6207713B1 (en) | 1997-09-17 | 1997-09-17 | Topical and oral delivery of arginine to cause beneficial effects |
US08/932,595 US5922332A (en) | 1997-09-17 | 1997-09-17 | Topical delivery of arginine to overcome pain |
US08/936,188 US5895658A (en) | 1997-09-17 | 1997-09-17 | Topical delivery of L-arginine to cause tissue warming |
PCT/US1998/019429 WO1999013717A1 (en) | 1997-09-17 | 1998-09-17 | A delivery of arginine to cause beneficial effects |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE456302T1 true ATE456302T1 (de) | 2010-02-15 |
Family
ID=27506014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98946099T ATE456302T1 (de) | 1997-09-17 | 1998-09-17 | Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1041880B1 (de) |
JP (3) | JP4352114B2 (de) |
AT (1) | ATE456302T1 (de) |
AU (1) | AU737199B2 (de) |
CA (1) | CA2303394C (de) |
DE (1) | DE69841481D1 (de) |
ES (2) | ES2549329T3 (de) |
WO (1) | WO1999013717A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7629384B2 (en) | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
US6284797B1 (en) * | 1999-04-12 | 2001-09-04 | Donald A. Rhodes | Topical treatment of pain and to promote healing |
JP2000327560A (ja) * | 1999-05-18 | 2000-11-28 | Noevir Co Ltd | 入浴剤組成物 |
FR2794974B1 (fr) * | 1999-06-16 | 2001-08-17 | Exsymol Sa | Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique |
US6322493B1 (en) * | 1999-07-01 | 2001-11-27 | 40 J's Llc | Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds |
JP4681132B2 (ja) * | 2001-01-29 | 2011-05-11 | 味の素株式会社 | 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物 |
DE10113446A1 (de) * | 2001-03-19 | 2002-09-26 | Schwarzkopf Gmbh Hans | Haarbehandlungsmittel mit Betainen |
AU2003213220A1 (en) * | 2002-02-22 | 2003-09-09 | Essentia Biosystems, Inc. | Cosmetic formulations containing l-arginine oligomers |
US7326717B2 (en) | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
CA2556967A1 (en) * | 2004-02-23 | 2005-09-09 | Strategic Science & Technologies, Llc | Topical delivery of a nitric oxide donor to improve body and skin appearance |
JP4837896B2 (ja) * | 2004-03-31 | 2011-12-14 | 焼津水産化学工業株式会社 | 精力増強剤 |
JP2005281272A (ja) * | 2004-03-31 | 2005-10-13 | Suntory Ltd | 末梢血流改善剤 |
JP4836044B2 (ja) * | 2004-04-02 | 2011-12-14 | 味の素株式会社 | 経口アミノ酸ニキビ治療剤 |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
EP2420241A1 (de) | 2004-04-19 | 2012-02-22 | Strategic Science & Technologies, LLC | Transdermale Abgabe von vorteilhaften Substanzen; die von einem feindlichen biophysischen Umfeld beeinflusst werden |
AU2012201048B2 (en) * | 2004-04-19 | 2013-06-06 | Strategic Science & Technologies, Llc | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
JP2007532697A (ja) * | 2004-04-19 | 2007-11-15 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 局所的血流増大の有益な効果 |
JP2006169406A (ja) * | 2004-12-16 | 2006-06-29 | Fuji Latex Kk | コンドーム用水性潤滑剤および当該潤滑剤を塗布したコンドーム |
JP2008179540A (ja) * | 2005-01-07 | 2008-08-07 | Noevir Co Ltd | 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤 |
EP1863431A1 (de) * | 2005-03-18 | 2007-12-12 | L'Oréal | Haar- und/oder wimpernpflegezusammensetzung mit aminexil in kombination mit einem mittel zur förderung der no-produktion und ihre verwendung |
FR2883167B1 (fr) * | 2005-03-18 | 2009-07-10 | Oreal | Composition de soin capillaire et/ou des cils contenant de l'aminexil en association avec un vasodilatateur, destinee a stimuler la croissance des cheveux et/ou des cils et/ou freiner leur chute, ses utilisations |
JP5046174B2 (ja) * | 2005-03-31 | 2012-10-10 | 味の素株式会社 | アルギニン含有血流増加用組成物 |
US8445536B2 (en) | 2005-03-31 | 2013-05-21 | Ajinomoto Co., Inc. | Arginine-containing compositions and methods for increasing blood flow using same |
NZ569535A (en) | 2005-12-30 | 2011-12-22 | Revance Therapeutics Inc | Arginine heteromers for topical administration |
WO2008089435A1 (en) * | 2007-01-18 | 2008-07-24 | Wyeth | Methods of identifying pain modulators |
EP2238981B1 (de) * | 2007-09-21 | 2014-07-23 | Pharmabrand S.A. | Zusammensetzung mit muzilaginösen polysacchariden aus aloe barbadensis in kombination mit liposomen, verfahren zu ihrer gewinnung und ihre verwendung als sonnenschutzmittel, anti-akne-mittel, epidermales regenerationsmittel und feuchtigkeitsspender |
FR2929118B1 (fr) * | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
AU2015203547B2 (en) * | 2009-06-24 | 2017-05-18 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
EP2445493A1 (de) * | 2009-06-24 | 2012-05-02 | Strategic Science & Technologies, LLC | Topische zusammensetzung mit naproxen |
MX337166B (es) * | 2009-06-24 | 2016-02-15 | Composicion topica que contiene ibuoprofeno. | |
CN103429247A (zh) | 2010-12-29 | 2013-12-04 | 战略科学与技术有限责任公司 | 勃起功能障碍和其它适应症的治疗 |
US9289495B2 (en) | 2010-12-29 | 2016-03-22 | Strategic Science & Technologies, Llc | Systems and methods for treatment of allergies and other indications |
CN105377233A (zh) | 2013-03-15 | 2016-03-02 | 战略科学与技术有限责任公司 | 氟替卡松的透皮制剂 |
WO2014152382A1 (en) | 2013-03-15 | 2014-09-25 | Strategic Science & Technologies, Llc | Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors |
WO2016094316A1 (en) * | 2014-12-08 | 2016-06-16 | Synaptamine, Inc. | Anti-rds compounds and method of manufacture and administration thereof to induce dopamine homeostatis |
WO2016112201A1 (en) | 2015-01-07 | 2016-07-14 | Strategic Science & Technologies, Llc | Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications |
MY176129A (en) | 2015-08-06 | 2020-07-24 | Coats Agri Aloe Llc | Compositions and methods to increase plant yield |
GB201620701D0 (en) * | 2016-12-06 | 2017-01-18 | Glaxosmithkline Consumer Healthcare (Uk) Ip Ltd | Novel composition |
CN110870914A (zh) * | 2018-08-31 | 2020-03-10 | 成都夸常奥普医疗科技有限公司 | 氨基酸类营养素的应用以及包含它的药物组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR5940M (de) * | 1966-10-18 | 1968-04-08 | ||
FR2602678B1 (fr) * | 1986-08-13 | 1992-06-05 | Drouault Guy | Composition pharmaceutique aqueuse a base de sels de magnesium, sodium et potassium pour la regulation des circulations locales |
PT95564B (pt) * | 1989-10-17 | 1997-11-28 | Merck & Co Inc | Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado |
JPH045231A (ja) * | 1990-04-20 | 1992-01-09 | Morishita Pharmaceut Co Ltd | 慢性痛用鎮痛剤 |
JPH0789862A (ja) * | 1990-05-29 | 1995-04-04 | Toyobo Co Ltd | 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法 |
DE4100975A1 (de) * | 1991-01-15 | 1992-07-16 | Weuffen Wolfgang | Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums |
US5852058A (en) * | 1993-06-11 | 1998-12-22 | The Board Of Trustees Of The Leland Stanford Junior University | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
DE4338793A1 (de) * | 1993-11-12 | 1995-05-18 | Froelich Juergen C | L-Arginin und Analoge als Thrombozytenaggregationshemmer |
DE4341000A1 (de) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen |
US5594032A (en) * | 1994-11-10 | 1997-01-14 | Gonzalez-Cadavid; Nestor F. | Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
US5595753A (en) * | 1995-04-14 | 1997-01-21 | President And Fellows Of Harvard College | Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract |
US5734080A (en) * | 1995-09-22 | 1998-03-31 | Anihealth Corporation | Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof |
-
1998
- 1998-09-17 ES ES09014985.7T patent/ES2549329T3/es not_active Expired - Lifetime
- 1998-09-17 EP EP98946099A patent/EP1041880B1/de not_active Expired - Lifetime
- 1998-09-17 CA CA2303394A patent/CA2303394C/en not_active Expired - Fee Related
- 1998-09-17 ES ES98946099T patent/ES2340450T3/es not_active Expired - Lifetime
- 1998-09-17 AT AT98946099T patent/ATE456302T1/de not_active IP Right Cessation
- 1998-09-17 AU AU93186/98A patent/AU737199B2/en not_active Ceased
- 1998-09-17 WO PCT/US1998/019429 patent/WO1999013717A1/en active IP Right Grant
- 1998-09-17 DE DE69841481T patent/DE69841481D1/de not_active Expired - Lifetime
- 1998-09-17 EP EP09014985.7A patent/EP2158907B1/de not_active Expired - Lifetime
- 1998-09-17 JP JP2000511359A patent/JP4352114B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-31 JP JP2009084491A patent/JP2009143968A/ja active Pending
-
2014
- 2014-10-07 JP JP2014206221A patent/JP2015038119A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2303394A1 (en) | 1999-03-25 |
AU737199B2 (en) | 2001-08-09 |
EP2158907A3 (de) | 2010-05-26 |
AU9318698A (en) | 1999-04-05 |
JP2009143968A (ja) | 2009-07-02 |
EP1041880A4 (de) | 2006-04-12 |
EP2158907A2 (de) | 2010-03-03 |
CA2303394C (en) | 2011-12-20 |
WO1999013717B1 (en) | 1999-04-22 |
EP1041880B1 (de) | 2010-01-27 |
JP2015038119A (ja) | 2015-02-26 |
DE69841481D1 (de) | 2010-03-18 |
EP1041880A1 (de) | 2000-10-11 |
JP4352114B2 (ja) | 2009-10-28 |
ES2549329T3 (es) | 2015-10-27 |
ES2340450T3 (es) | 2010-06-02 |
JP2002515401A (ja) | 2002-05-28 |
WO1999013717A1 (en) | 1999-03-25 |
EP2158907B1 (de) | 2015-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE456302T1 (de) | Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe | |
US20030018076A1 (en) | Topical and oral arginine to cause beneficial effects | |
ATE30209T1 (de) | Verwendung von eukalyptol zur steigerung der resorption von bioaktiven substanzen durch die haut. | |
NZ513154A (en) | Therapeutic and/or cosmetic formulations comprising antisense polynucleotides to connexin proteins | |
MX9306239A (es) | Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma. | |
DE69613840D1 (de) | Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle | |
AU581121B2 (en) | Skin treatment composition | |
BR0317888A (pt) | Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos | |
IL138290A0 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
DE69219470D1 (de) | Topisches Präparat zur besseren Heilung von Herpesverletzungen | |
ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
ATE224727T1 (de) | Faktor xiii zur behandlung von hautwunden | |
PT1016414E (pt) | Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos | |
PT1140001E (pt) | Composicao para tratamento de queimaduras | |
FR2786699B1 (fr) | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles | |
DE69825322D1 (de) | Topische carbamazepin-formulierungen und deren verwendung | |
CA2115045A1 (en) | Composition for Curing Proliferative Skin Diseases | |
EP1328273A4 (de) | Hilfsmittel und methoden zur transdermalen applikation von felodipin | |
CN1079667A (zh) | 一种烫伤药 | |
RU96100994A (ru) | Лечебно-косметическое средство | |
UA29005A (uk) | Спосіб лікування трофічних виразок нижніх кінцівок |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |